383 related articles for article (PubMed ID: 19549078)
1. Redistribution of slow wave activity of sleep during pharmacological treatment of depression with paroxetine but not with nefazodone.
Argyropoulos SV; Hicks JA; Nash JR; Bell CJ; Rich AS; Nutt DJ; Wilson S
J Sleep Res; 2009 Sep; 18(3):342-8. PubMed ID: 19549078
[TBL] [Abstract][Full Text] [Related]
2. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
Baldwin DS; Hawley CJ; Abed RT; Maragakis BP; Cox J; Buckingham SA; Pover GH; Ascher A
J Clin Psychiatry; 1996; 57 Suppl 2():46-52. PubMed ID: 8626363
[TBL] [Abstract][Full Text] [Related]
3. Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.
Barbanoj MJ; Clos S; Romero S; Morte A; Giménez S; Lorenzo JL; Luque A; Dal-Ré R
Neuropsychobiology; 2005; 51(3):134-47. PubMed ID: 15838185
[TBL] [Abstract][Full Text] [Related]
4. A comparison of nefazodone and fluoxetine on mood and on objective, subjective, and clinician-rated measures of sleep in depressed patients: a double-blind, 8-week clinical trial.
Gillin JC; Rapaport M; Erman MK; Winokur A; Albala BJ
J Clin Psychiatry; 1997 May; 58(5):185-92. PubMed ID: 9184611
[TBL] [Abstract][Full Text] [Related]
5. Randomised controlled study of sleep after nefazodone or paroxetine treatment in out-patients with depression.
Hicks JA; Argyropoulos SV; Rich AS; Nash JR; Bell CJ; Edwards C; Nutt DJ; Wilson SJ
Br J Psychiatry; 2002 Jun; 180():528-35. PubMed ID: 12042232
[TBL] [Abstract][Full Text] [Related]
6. Maintenance nortriptyline effects on electroencephalographic sleep in elderly patients with recurrent major depression: double-blind, placebo- and plasma-level-controlled evaluation.
Reynolds CF; Buysse DJ; Brunner DP; Begley AE; Dew MA; Hoch CC; Hall M; Houck PR; Mazumdar S; Perel JM; Kupfer DJ
Biol Psychiatry; 1997 Oct; 42(7):560-7. PubMed ID: 9376452
[TBL] [Abstract][Full Text] [Related]
7. Accelerating response in geriatric depression: a pilot study combining sleep deprivation and paroxetine.
Bump GM; Reynolds CF; Smith G; Pollock BG; Dew MA; Mazumdar S; Geary M; Houck PR; Kupfer DJ
Depress Anxiety; 1997; 6(3):113-8. PubMed ID: 9442985
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of trimipramine and fluoxetine on sleep in geriatric depression.
Wolf R; Dykierek P; Gattaz WF; Maras A; Kohnen R; Dittmann RW; Geuppert M; Riemann D; Berger M
Pharmacopsychiatry; 2001 Mar; 34(2):60-5. PubMed ID: 11302565
[TBL] [Abstract][Full Text] [Related]
9. Effects of paroxetine on human sleep.
Oswald I; Adam K
Br J Clin Pharmacol; 1986 Jul; 22(1):97-9. PubMed ID: 2943309
[TBL] [Abstract][Full Text] [Related]
10. Paroxetine serum concentrations in depressed patients and response to treatment.
Gilles M; Deuschle M; Kellner S; Shams M; Krumm B; Härtter S; Heuser I; Hiemke C
Pharmacopsychiatry; 2005 May; 38(3):118-21. PubMed ID: 15902581
[TBL] [Abstract][Full Text] [Related]
11. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).
Wade AG; Schlaepfer TE; Andersen HF; Kilts CD
J Psychiatr Res; 2009 Feb; 43(5):568-75. PubMed ID: 18954875
[TBL] [Abstract][Full Text] [Related]
12. Nefazodone treatment of cocaine dependence with comorbid depressive symptoms.
Ciraulo DA; Knapp C; Rotrosen J; Sarid-Segal O; Ciraulo AM; LoCastro J; Greenblatt DJ; Leiderman D
Addiction; 2005 Mar; 100 Suppl 1():23-31. PubMed ID: 15730347
[TBL] [Abstract][Full Text] [Related]
13. Superiority of escitalopram to paroxetine in the treatment of depression.
Kasper S; Baldwin DS; Larsson Lönn S; Boulenger JP
Eur Neuropsychopharmacol; 2009 Apr; 19(4):229-37. PubMed ID: 19185467
[TBL] [Abstract][Full Text] [Related]
14. The safety profile of nefazodone.
Robinson DS; Roberts DL; Smith JM; Stringfellow JC; Kaplita SB; Seminara JA; Marcus RN
J Clin Psychiatry; 1996; 57 Suppl 2():31-8. PubMed ID: 8626361
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder.
Rush AJ; Armitage R; Gillin JC; Yonkers KA; Winokur A; Moldofsky H; Vogel GW; Kaplita SB; Fleming JB; Montplaisir J; Erman MK; Albala BJ; McQuade RD
Biol Psychiatry; 1998 Jul; 44(1):3-14. PubMed ID: 9646878
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic dose range of nefazodone in the treatment of major depression.
Robinson DS; Marcus RN; Archibald DG; Hardy SA
J Clin Psychiatry; 1996; 57 Suppl 2():6-9. PubMed ID: 8626365
[TBL] [Abstract][Full Text] [Related]
17. The effects of nefazodone on sleep architecture in depression.
Armitage R; Rush AJ; Trivedi M; Cain J; Roffwarg HP
Neuropsychopharmacology; 1994 Apr; 10(2):123-7. PubMed ID: 8024673
[TBL] [Abstract][Full Text] [Related]
18. Time course of response to paroxetine: influence of plasma level.
Gex-Fabry M; Gervasoni N; Eap CB; Aubry JM; Bondolfi G; Bertschy G
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):892-900. PubMed ID: 17395353
[TBL] [Abstract][Full Text] [Related]
19. Nefazodone in primary insomnia: an open pilot study.
Wiegand MH; Galanakis P; Schreiner R
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1071-8. PubMed ID: 15610919
[TBL] [Abstract][Full Text] [Related]
20. [Biological models of depression: effect of antidepressants on sleep].
Viot-Blanc V
Encephale; 1995 Dec; 21 Spec No 7():35-40. PubMed ID: 8929677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
